Shukla Akash, Giri Suprabhat
Department of Gastroenterology, Seth GS Medical College and KEM Hospital, Mumbai, India.
J Clin Exp Hepatol. 2022 May-Jun;12(3):965-979. doi: 10.1016/j.jceh.2021.11.003. Epub 2021 Nov 22.
Patients with cirrhosis of the liver are at high risk of developing portal vein thrombosis (PVT), which has a complex, multifactorial cause. The condition may present with a myriad of symptoms and can occasionally cause severe complications. Contrast-enhanced computed tomography (CT) is the gold standard for the diagnosis of PVT. There are uncertainties regarding the effect on PVT and its treatment outcome in patients with cirrhosis. The main challenge for managing PVT in cirrhosis is analyzing the risk of hemorrhage compared to the risk of thrombus extension leading to complications. All current knowledge regarding non-tumor PVT in cirrhosis, including epidemiology, risk factors, classification, clinical presentation, diagnosis, impact on natural history, and treatment, is discussed in the present article.
肝硬化患者发生门静脉血栓形成(PVT)的风险很高,其病因复杂且多因素。该病症可能表现出多种症状,偶尔会导致严重并发症。对比增强计算机断层扫描(CT)是诊断PVT的金标准。对于肝硬化患者中PVT的影响及其治疗结果存在不确定性。肝硬化患者PVT管理的主要挑战是分析出血风险与血栓扩展导致并发症的风险。本文讨论了目前关于肝硬化非肿瘤性PVT的所有知识,包括流行病学、危险因素、分类、临床表现、诊断、对自然病程的影响以及治疗。